Blogs: News & Views

Compounding Pharmacies: The Firestorm

Published Online: Monday, November 19, 2012
Compounding has been making headlines in the national news lately as a result of a compounding pharmacy in Massachusetts that has been linked to a serious meningitis outbreak—and 29 subsequent deaths—and the firestorm shows no signs of slowing down. On November 1, USA Today published "Harsh Punishments Rare for Compounding Mistakes" and the article gives all of pharmacy a black eye. Even though the details of this particular case reflect a specific company that has been seriously derelict, the media coverage paints pharmacy in a negative light and creates repercussions for the entire industry.
Many independent pharmacies around the country have developed compounding into a business that supports the needs of their community. These entrepreneurs are filling a market niche with specialized local service. But when a compounding pharmacy, such as the New England Compounding Center (NECC), acts as a drug manufacturer, producing drugs on a large scale, the story can change dramatically. This high-volume compounding operation endangered the public.
What kind of oversight has there been to regulate compounding pharmacies? This is done on the state level, but compared with other states, the Massachusetts pharmacy board has "suffered from a lack of transparency and efficiency," according an editorial appearing in the Boston Globe. The newspaper reported that while the state has now issued emergency regulations that tighten the oversight of compounding pharmacies, the governor has also appointed a commission to review the problem.
Already, there is a call for the federal government to step in because the state did not react appropriately or quickly enough to avert this disaster. But one must ask if this is really the best plan, especially in light of the fact that more government intervention can result in making the situation worse, not better. What about the many compounding pharmacists who are serving their patients very well with their compounding services? Just because this New England company aggressively sought to expand under extremely lax oversight, does it mean that all compounding pharmacies should pay the price with federal intervention?
Pharmacy must step up and regain the public trust with more information, more transparency, and better responses to violators. If this is not done by the states and individual pharmacists, with support from the national pharmacy associations, we can expect the situation to create policy that can only threaten the entrepreneurs in the industry. The new bill just announced by US Representative Edward Markey (D-Mass) is a case in point.
The National Community Pharmacists Association (NCPA) has weighed in on the situation, and it is worthwhile to read the association's stance. Although the NCPA acknowledges that the bill represents an identified problem, they say, "The proposed legislation also appears to create new overly board requirements on traditional pharmacy compounding that could negatively impact both patients' access to essential medications and the community pharmacists who provide them. As currently drafted, the legislation would grant powers to an already stretched Food and Drug Administration to regulate traditional pharmacy compounding, and create new roadblocks for patients by requiring waivers for pharmacists to make medications they have been making safely and effectively for decades."
No doubt, pharmacists across the country will be watching the Massachusetts story closely.
Thank you for reading!
Mike Hennessy
Chairman/Chief Executive Officer/President
Mike Hennessy, Chairman and CEO
Blog Info
Mike Hennessy shares his views and perspectives on issues that affect pharmacists.
Author Bio
ABOUT MIKE HENNESSY, President, Chairman, CEO

Mike Hennessy is President, Chairman, and CEO of MJH & Associates and Intellisphere, LLC, publisher of influential journals in health care, finance, and politics, including Pharmacy Times. Pharmacy Times is a clinically based, monthly journal providing practical information pharmacists can use in their everyday practice. Each issue contains articles and features covering medication errors, drug interactions, patient education, pharmacy technology, disease state management watches, patient counseling, product news, pharmacy law, and specialty pharmacy. Pharmacy Times is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of free continuing pharmacy education.

As a businessman, entrepreneur, and publisher of magazines, iPad editions, projects, and Web sites that focus on the needs of health care professionals, Hennessy is intimately familiar with the challenges these professionals face every day in today's competitive practice environment. News & Views: Hennessy's Highlights dissects health care policy issues, the impact of pharmacy on national health care, and the critical issues that concern pharmacists as the new health care reform legislation is debated.

As publisher of Pharmacy Times, Mr. Hennessy launched the Next-Generation Pharmacist Awards in partnership with Parata Systems, to recognize the achievements of pharmacists in health care. "As the leader in pharmacy publishing, Pharmacy Times is shining a light on the critical role of the pharmacist in today's health care world and providing invaluable insight into the profession," Mike Hennessy, chairman, chief executive officer, and president said. "We are proud to recognize individual pharmacists in this 2nd annual awards program."

Pharmacy Times is published by Intellisphere, LLC, a leading provider of health care publishing, research, information, and education. Operating within both traditional and digital media channels, Intellisphere serves the needs of health care professionals through an extensive suite of magazines, journals, e-mail databases, Web sites, events and personal meetings. Intellisphere reaches more than half a million health care professionals through Pharmacy Times, Specialty Pharmacy Times, The American Journal of Managed Care, The American Journal of Pharmacy Benefits, MDNG,, Oncology & Biotech News, Oncology Net Guide, Contemporary Oncology, and Oncology Net Guide: Nurses' Edition.
Blog Archive
Latest Issues